Applications of pox virus vectors to vaccination: an update.
Recombinant pox viruses have been generated for vaccination against heterologous pathogens. Amongst these, the following are notable examples. (i) The engineering of the Copenhagen strain of vaccinia virus to express the rabies virus glycoprotein. When applied in baits, this recombinant has been shown to vaccinate the red fox in Europe and raccoons in the United States, stemming the spread of rabies virus infection in the wild. (ii) A fowlpox-based recombinant expressing the Newcastle disease virus fusion and hemagglutinin glycoproteins has been shown to protect commercial broiler chickens for their lifetime when the vaccine was administered at 1 day of age, even in the presence of maternal immunity against either the Newcastle disease virus or the pox vector. (iii) Recombinants of canarypox virus, which is restricted for replication to avian species, have provided protection against rabies virus challenge in cats and dogs, against canine distemper virus, feline leukemia virus, and equine influenza virus disease. In humans, canarypox virus-based recombinants expressing antigens from rabies virus, Japanese encephalitis virus, and HIV have been shown to be safe and immunogenic. (iv) A highly attenuated vaccinia derivative, NYVAC, has been engineered to express antigens from both animal and human pathogens. Safety and immunogenicity of NYVAC-based recombinants expressing the rabies virus glycoprotein, a polyprotein from Japanese encephalitis virus, and seven antigens from Plasmodium falciparum have been demonstrated to be safe and immunogenic in early human vaccine studies.
Paoletti
E
E
D016915:AIDS Vaccines; D000818:Animals; D001717:Birds; D002415:Cats; D002645:Chickens; D004285:Dogs; D005589:Foxes; D005822:Genetic Vectors; D006801:Humans; D011212:Poxviridae; D011818:Rabies / Q000276:immunology / Q000517:prevention & control; D011821:Raccoons; D013045:Species Specificity; D014614:Vaccines, Synthetic; D014616:Vaccinia virus; D014765:Viral Vaccines
D016915:AIDS Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines